Arama Sonu&ccedil;lar&#305; Therapeutics - Daralt&#305;lm&#305;&#351;: Oncology. SirsiDynix Enterprise https://katalog.hacettepe.edu.tr/client/tr_TR/default_tr/default_tr/qu$003dTherapeutics$0026qf$003dSUBJECT$002509Konu$002509Oncology.$002509Oncology.$0026ps$003d300$0026isd$003dtrue? 2024-11-11T06:09:11Z Macromolecular Anticancer Therapeutics ent://SD_ILS/0/SD_ILS:171982 2024-11-11T06:09:11Z 2024-11-11T06:09:11Z Yazar&#160;Reddy, L. Harivardhan. editor.&#160;Couvreur, Patrick. editor.&#160;SpringerLink (Online service)<br/>Yer Numaras&#305;&#160;ONLINE<br/>Elektronik Eri&#351;im&#160;<a href="http://dx.doi.org/10.1007/978-1-4419-0507-9">http://dx.doi.org/10.1007/978-1-4419-0507-9</a><br/>Format:&#160;Elektrnik Kaynak<br/>Durum&#160;&Ccedil;evrimi&ccedil;i K&uuml;t&uuml;phane~1<br/> Targeted Therapeutics in Melanoma ent://SD_ILS/0/SD_ILS:175131 2024-11-11T06:09:11Z 2024-11-11T06:09:11Z Yazar&#160;Gajewski, Thomas F. editor.&#160;Hodi, F. Stephen. editor.&#160;SpringerLink (Online service)<br/>Yer Numaras&#305;&#160;ONLINE<br/>Elektronik Eri&#351;im&#160;<a href="http://dx.doi.org/10.1007/978-1-61779-407-0">http://dx.doi.org/10.1007/978-1-61779-407-0</a><br/>Format:&#160;Elektrnik Kaynak<br/>Durum&#160;&Ccedil;evrimi&ccedil;i K&uuml;t&uuml;phane~1<br/> Pharmaceutical Perspectives of Cancer Therapeutics ent://SD_ILS/0/SD_ILS:171872 2024-11-11T06:09:11Z 2024-11-11T06:09:11Z Yazar&#160;Lu, Yi. editor.&#160;Mahato, Ram I. editor.&#160;SpringerLink (Online service)<br/>Yer Numaras&#305;&#160;ONLINE<br/>Elektronik Eri&#351;im&#160;<a href="http://dx.doi.org/10.1007/978-1-4419-0131-6">http://dx.doi.org/10.1007/978-1-4419-0131-6</a><br/>Format:&#160;Elektrnik Kaynak<br/>Durum&#160;&Ccedil;evrimi&ccedil;i K&uuml;t&uuml;phane~1<br/> Stem Cell Research and Therapeutics ent://SD_ILS/0/SD_ILS:170198 2024-11-11T06:09:11Z 2024-11-11T06:09:11Z Yazar&#160;Shi, Yanhong. editor.&#160;Clegg, Dennis O. editor.&#160;SpringerLink (Online service)<br/>Yer Numaras&#305;&#160;ONLINE<br/>Elektronik Eri&#351;im&#160;<a href="http://dx.doi.org/10.1007/978-1-4020-8502-4">http://dx.doi.org/10.1007/978-1-4020-8502-4</a><br/>Format:&#160;Elektrnik Kaynak<br/>Durum&#160;&Ccedil;evrimi&ccedil;i K&uuml;t&uuml;phane~1<br/> Bone Metastasis Experimental and Clinical Therapeutics ent://SD_ILS/0/SD_ILS:174523 2024-11-11T06:09:11Z 2024-11-11T06:09:11Z Yazar&#160;Singh, Gurmit. editor.&#160;Rabbani, Shafaat A. editor.&#160;SpringerLink (Online service)<br/>Yer Numaras&#305;&#160;ONLINE<br/>Elektronik Eri&#351;im&#160;<a href="http://dx.doi.org/10.1385/1592598927">http://dx.doi.org/10.1385/1592598927</a><br/>Format:&#160;Elektrnik Kaynak<br/>Durum&#160;&Ccedil;evrimi&ccedil;i K&uuml;t&uuml;phane~1<br/> Resistance to Anti-Cancer Therapeutics Targeting Receptor Tyrosine Kinases and Downstream Pathways ent://SD_ILS/0/SD_ILS:400866 2024-11-11T06:09:11Z 2024-11-11T06:09:11Z Yazar&#160;Yarden, Yosef. editor.&#160;Elkabets, Moshe. editor.&#160;SpringerLink (Online service)<br/>Yer Numaras&#305;&#160;ONLINE<br/>Elektronik Eri&#351;im&#160;<a href="https://doi.org/10.1007/978-3-319-67932-7">https://doi.org/10.1007/978-3-319-67932-7</a><br/>Format:&#160;Elektrnik Kaynak<br/>Durum&#160;&Ccedil;evrimi&ccedil;i K&uuml;t&uuml;phane~1<br/> Design and Evaluation of Plasmonic/Magnetic Au-MFe2O4 (M-Fe/Co/Mn) Core-Shell Nanoparticles Functionalized with Doxorubicin for Cancer Therapeutics ent://SD_ILS/0/SD_ILS:402161 2024-11-11T06:09:11Z 2024-11-11T06:09:11Z Yazar&#160;Manisekaran, Ravichandran. author.&#160;SpringerLink (Online service)<br/>Yer Numaras&#305;&#160;ONLINE<br/>Elektronik Eri&#351;im&#160;<a href="https://doi.org/10.1007/978-3-319-67609-8">https://doi.org/10.1007/978-3-319-67609-8</a><br/>Format:&#160;Elektrnik Kaynak<br/>Durum&#160;&Ccedil;evrimi&ccedil;i K&uuml;t&uuml;phane~1<br/> Hematologic Cancers: From Molecular Pathobiology to Targeted Therapeutics ent://SD_ILS/0/SD_ILS:206728 2024-11-11T06:09:11Z 2024-11-11T06:09:11Z Yazar&#160;Tao, Jianguo. editor.&#160;Sotomayor, Eduardo. editor.&#160;SpringerLink (Online service)<br/>Yer Numaras&#305;&#160;ONLINE<br/>Elektronik Eri&#351;im&#160;<a href="http://dx.doi.org/10.1007/978-94-007-5028-9">http://dx.doi.org/10.1007/978-94-007-5028-9</a><br/>Format:&#160;Elektrnik Kaynak<br/>Durum&#160;&Ccedil;evrimi&ccedil;i K&uuml;t&uuml;phane~1<br/> Insulin-like Growth Factors and Cancer From Basic Biology to Therapeutics ent://SD_ILS/0/SD_ILS:173729 2024-11-11T06:09:11Z 2024-11-11T06:09:11Z Yazar&#160;LeRoith, Derek. editor.&#160;SpringerLink (Online service)<br/>Yer Numaras&#305;&#160;ONLINE<br/>Elektronik Eri&#351;im&#160;<a href="http://dx.doi.org/10.1007/978-1-4614-0598-6">http://dx.doi.org/10.1007/978-1-4614-0598-6</a><br/>Format:&#160;Elektrnik Kaynak<br/>Durum&#160;&Ccedil;evrimi&ccedil;i K&uuml;t&uuml;phane~1<br/> Prostate Cancer Biology, Genetics, and the New Therapeutics ent://SD_ILS/0/SD_ILS:174683 2024-11-11T06:09:11Z 2024-11-11T06:09:11Z Yazar&#160;Chung, Leland W. K. editor.&#160;Isaacs, William B. editor.&#160;Simons, Jonathan W. editor.&#160;SpringerLink (Online service)<br/>Yer Numaras&#305;&#160;ONLINE<br/>Elektronik Eri&#351;im&#160;<a href="http://dx.doi.org/10.1007/978-1-59745-224-3">http://dx.doi.org/10.1007/978-1-59745-224-3</a><br/>Format:&#160;Elektrnik Kaynak<br/>Durum&#160;&Ccedil;evrimi&ccedil;i K&uuml;t&uuml;phane~1<br/> Resistance of Targeted Therapies Excluding Antibodies for Lymphomas ent://SD_ILS/0/SD_ILS:401396 2024-11-11T06:09:11Z 2024-11-11T06:09:11Z Yazar&#160;Ferreri, Andr&eacute;s J. M. editor.&#160;SpringerLink (Online service)<br/>Yer Numaras&#305;&#160;ONLINE<br/>Elektronik Eri&#351;im&#160;<a href="https://doi.org/10.1007/978-3-319-75184-9">https://doi.org/10.1007/978-3-319-75184-9</a><br/>Format:&#160;Elektrnik Kaynak<br/>Durum&#160;&Ccedil;evrimi&ccedil;i K&uuml;t&uuml;phane~1<br/> Resistance to Ibritumomab in Lymphoma ent://SD_ILS/0/SD_ILS:400896 2024-11-11T06:09:11Z 2024-11-11T06:09:11Z Yazar&#160;Hosono, Makoto. editor.&#160;Chatal, Jean-Fran&ccedil;ois. editor.&#160;SpringerLink (Online service)<br/>Yer Numaras&#305;&#160;ONLINE<br/>Elektronik Eri&#351;im&#160;<a href="https://doi.org/10.1007/978-3-319-78238-6">https://doi.org/10.1007/978-3-319-78238-6</a><br/>Format:&#160;Elektrnik Kaynak<br/>Durum&#160;&Ccedil;evrimi&ccedil;i K&uuml;t&uuml;phane~1<br/> Molecular Mechanisms of Tumor Cell Resistance to Chemotherapy Targeted Therapies to Reverse Resistance ent://SD_ILS/0/SD_ILS:332198 2024-11-11T06:09:11Z 2024-11-11T06:09:11Z Yazar&#160;Bonavida, Benjamin. editor.&#160;SpringerLink (Online service)<br/>Yer Numaras&#305;&#160;ONLINE(332198.1)<br/>Elektronik Eri&#351;im&#160;<a href="http://dx.doi.org/10.1007/978-1-4614-7070-0">http://dx.doi.org/10.1007/978-1-4614-7070-0</a><br/>Format:&#160;Elektrnik Kaynak<br/>Durum&#160;&Ccedil;evrimi&ccedil;i K&uuml;t&uuml;phane~1<br/> Resistance to Immunotherapeutic Antibodies in Cancer Strategies to Overcome Resistance ent://SD_ILS/0/SD_ILS:332319 2024-11-11T06:09:11Z 2024-11-11T06:09:11Z Yazar&#160;Bonavida, Benjamin. editor.&#160;SpringerLink (Online service)<br/>Yer Numaras&#305;&#160;ONLINE(332319.1)<br/>Elektronik Eri&#351;im&#160;<a href="http://dx.doi.org/10.1007/978-1-4614-7654-2">http://dx.doi.org/10.1007/978-1-4614-7654-2</a><br/>Format:&#160;Elektrnik Kaynak<br/>Durum&#160;&Ccedil;evrimi&ccedil;i K&uuml;t&uuml;phane~1<br/>